BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 17437408)

  • 21. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
    Bankstahl JP; Löscher W
    Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver.
    Paulusma CC; Kothe MJ; Bakker CT; Bosma PJ; van Bokhoven I; van Marle J; Bolder U; Tytgat GN; Oude Elferink RP
    Hepatology; 2000 Mar; 31(3):684-93. PubMed ID: 10706559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s).
    Hori S; Ohtsuki S; Tachikawa M; Kimura N; Kondo T; Watanabe M; Nakashima E; Terasaki T
    J Neurochem; 2004 Aug; 90(3):526-36. PubMed ID: 15255930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats.
    van Vliet EA; Redeker S; Aronica E; Edelbroek PM; Gorter JA
    Epilepsia; 2005 Oct; 46(10):1569-80. PubMed ID: 16190927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of P-glycoprotein and non-P-glycoprotein effects on drug permeability using intestinal tissues from mdr1a (-/-) mice.
    Stephens RH; O'Neill CA; Bennett J; Humphrey M; Henry B; Rowland M; Warhurst G
    Br J Pharmacol; 2002 Apr; 135(8):2038-46. PubMed ID: 11959808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of trabectedin (ET-743) hepatobiliary disposition by multidrug resistance-associated proteins (Mrps) may prevent hepatotoxicity.
    Lee JK; Leslie EM; Zamek-Gliszczynski MJ; Brouwer KL
    Toxicol Appl Pharmacol; 2008 Apr; 228(1):17-23. PubMed ID: 18191164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB.
    Zhang J; Zhang M; Sun B; Li Y; Xu P; Liu C; Liu L; Liu X
    J Neurochem; 2014 Dec; 131(6):791-802. PubMed ID: 25200138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse.
    Vautier S; Lacomblez L; Chacun H; Picard V; Gimenez F; Farinotti R; Fernandez C
    Eur J Pharm Sci; 2006 Feb; 27(2-3):167-74. PubMed ID: 16263252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1.
    Zamek-Gliszczynski MJ; Hoffmaster KA; Tian X; Zhao R; Polli JW; Humphreys JE; Webster LO; Bridges AS; Kalvass JC; Brouwer KL
    Drug Metab Dispos; 2005 Aug; 33(8):1158-65. PubMed ID: 15860656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roles of P-glycoprotein, Bcrp, and Mrp2 in biliary excretion of spiramycin in mice.
    Tian X; Li J; Zamek-Gliszczynski MJ; Bridges AS; Zhang P; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3230-4. PubMed ID: 17576841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
    Lemmen J; Tozakidis IE; Bele P; Galla HJ
    Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered glycaemia differentially modulates efflux transporter expression and activity in hCMEC/D3 cell line.
    Sajja RK; Cucullo L
    Neurosci Lett; 2015 Jun; 598():59-65. PubMed ID: 25982326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier.
    Ose A; Kusuhara H; Yamatsugu K; Kanai M; Shibasaki M; Fujita T; Yamamoto A; Sugiyama Y
    Drug Metab Dispos; 2008 Feb; 36(2):427-34. PubMed ID: 18039806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
    Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier.
    Wanek T; Mairinger S; Langer O
    J Labelled Comp Radiopharm; 2013; 56(3-4):68-77. PubMed ID: 24285312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.
    Hosoya KI; Takashima T; Tetsuka K; Nagura T; Ohtsuki S; Takanaga H; Ueda M; Yanai N; Obinata M; Terasaki T
    J Drug Target; 2000; 8(6):357-70. PubMed ID: 11328662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient increase of P-glycoprotein expression in endothelium and parenchyma of limbic brain regions in the kainate model of temporal lobe epilepsy.
    Seegers U; Potschka H; Löscher W
    Epilepsy Res; 2002 Oct; 51(3):257-68. PubMed ID: 12399076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.